Pathophysiology of aortic cross-clamping and unclamping

Bailliere's Best Practice and Research in Clinical Anaesthesiology

Volumn 14, Issue 1, 2000, Pages 143-160

  Posner, Matthew ^a   Gelman, Simon ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aortic cross clamping; Aortic surger; Complications; Haemodynamic; Humoral; Pathophysiology

Indexed keywords

AORTA CLAMPING; AORTA SURGERY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEMODYNAMIC PARAMETERS; HUMORAL IMMUNITY; PATHOPHYSIOLOGY; PATIENT CARE; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

EID: 0033834368     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1053/bean.2000.0067     Document Type: Article

References (145)

1. The pathophysiology of aortic cross-clamping and unclamping
2. Thoracoabdominal aneurysm repair: A representative experience
3. Experience with 1509 patients undergoing thoracoabdominal aortic operations
4. Evolving experience with thoracoabdominal aortic aneurysm repair at a single institution
5. Multicenter prospective study of nonruptured abdominal aortic aneurysm: II. Variables predicting morbidity and mortality
6. Left ventricular function during aortic surgery
7. Haemodynamic changes due to clamping of the abdominal aorta
8. Skeletal muscle metabolism and central hemodynamics during temporary incomplete ischemia induced by aortic clamping in man
9. Continuous monitoring of mixed venous oxygen saturation during aortic surgery
10. The hemodynamics of temporary abdominal aortic occlusion
11. Myocardial ischemia due to infrarenal aortic cross-clamping during aortic surgery in patients with severe coronary artery disease
12. The effect of abdominal aortic cross-clamping in myocardial function
13. Hemodynamic and metabolic effects of abdominal aortic cross-clamping
14. Monitoring with two-dimensional transesophageal echocardiography: Comparison of myocardial function on patients undergoing supraceliac, suprarenal-infraceliac, or infrarenal aortic occlusion
15. Cardiovascular and hemodynamic functions in dogs subjects to prolonged aortic occlusion
16. The reason for cardiac reduction following aortic crossclamping
17. Avoiding the hemodynamic consequences of aortic crossclamping and unclamping
18. Inferior and superior vena caval blood flows during crossclamping of the thoracic aorta in pigs
19. Hemodynamics and oxygen uptake below and above aortic occlusion during crossclamping of the thoracic aortic and sodium nitroprusside infusion
20. Haemodynamic changes and oxygen uptake during crossclamping of the thoracic aorta in dexmedetomidine pretreated dogs
21. Excision of aneurysm of the ascending aorta with prosthetic replacement during cardiopulmonary bypass
22. Bypass flow requirements during thoracic aneurysmectomy with particular attention to the prevention of left heart failure
23. Clinical experience with pulsatile left heart bypass without anticoagulation for thoracic aneurysms
24. Results of the use of the TDMAC-heparin shunt in the surgery of aneurysms of the descending thoracic aorta
25. Nonpenetrating trauma to the thoracic aorta
26. Contributions of blood drainage from the liver, spleen and intestines to cardiac effects of aortic occlusion in the dog
27. Adequacy of ascending aorta-descending aorta shunt during cross-clamping of the thoracic aorta for prevention of spinal cord injury
28. Acute traumatic disruption of the thoracic aorta: A ten year experience
29. Right and left ventricular performance during and after abdominal aortic aneurysm repair
30. Hemodynamic and metabolic changes induced by temporary clamping of the thoracic aorta
31. The influence of adenosine triphosphate on left ventricular function and blood flow distribution during aortic crossclamping in dogs
32. Angiotensin and adrenoceptors in the hemodynamic response to aortic crossclamping
33. The influence of periaortic collateral vessels on the intraoperative hemodynamic effects of acute aortic occlusion in patients with aortoocclusive disease or abdominal aortic aneurysm
34. The influence of collateral vascularisation on haemodynamic performance during abdominal aortic surgery
35. Continuous monitoring of mixed venous oxygen saturation during aortic operations
36. Haemodynamic and metabolic consequences of aortic occlusion during abdominal aortic surgery
37. Cardiac and renal responses to cross-clamping of the descending thoracic aorta
38. The influence of high systemic blood pressures on the right ventricle and pulmonary circuit
39. Basic hemodynamic changes produced by aortic coarctation of different degrees
40. Experimental subendocardial ischemia in dogs with normal coronary arteries
41. Effect of nitroglycerin and aortic occlusion on myocardial blood flow
42. Heparin-coated shunts for lesions of the descending thoracic aorta
43. The effect of reninangiotensin system blockade on visceral blood flow during and after thoracic aortic crossclamping
44. Increased adenosine formation by rat myocardium with acute aortic constriction
45. Control of left ventricular and proximal aortic dimensional decompensation during clamping of the descending thoracic aorta
46. On the part played by the suprarenals in the normal vascular reactions of the body
47. The influence of variations in temperature and blood pressure on the performance of the isolated mammalian heart
48. The regulation of the heart beat
49. The regulation of the performance of the heart
50. The Anrep reconsidered
51. Regional myocardial blood flow after sudden aortic constriction in awake dogs
52. Positive inotropic response to inosine in the in situ canine heart
53. Effects of fluorocarbons, chlorinated solvents and inosine on the cardiopulmonary system
54. Nonmetabolically coupled coronary vasodilation during inosine infusion in dogs
55. Inosine as a cardiotonic agent that reverses adrenergic beta-blockade
56. Effects of inosine on contractile force and high-energy phosphates in ischemic hearts (40575)
57. Effects of anesthesia, tachycardia, and autonomic blockade on the Anrep effect in intact dogs
58. Regional coronary venous oxygen saturation and myocardial oxygen tension following abrupt changes in ventricular pressure in the isolated dog heart
59. Haemodynamic response to infrarenal aortic cross-clamping in patients with and without coronary artery disease
60. Hemodynamic effects of infrarenal and common iliac artery declamping in man: An approach to optimal volume loading
61. Cross-clamping of the descending aorta
62. Catecholamine release during and after crossclamping of the descending aorta
63. Angiotensin and adrenoceptors' role in hemodynamic response to aortic cross-clamping
64. Vasodepressor factor in declamp shock production
65. Cardiac response to increased aortic pressure: Changes in output and left ventricular pressure pattern at various levels of inotropy
66. Hemodynamics of intravenous nitroglycerin during aortic clamping
67. The use of aminophylline for correction of haemodynamic repercussions of clamping of the aorta
68. Nitroglycerin infusion during infrarenal aortic cross-clamping in dogs: An experimental study
69. Mechanism of hypotension following release of abdominal aortic clamps
70. Intravenous captopril for treatment of hypertension in patients undergoing abdominal aortic surgery
71. A positive feedback sympathetic pressor reflex during stretch of the thoracic aorta in conscious dogs
72. Cardiovascular reflexes mediated by sympathetic afferent fibers
73. Reflex hemodynamic responses initiated from the thoracic aorta
74. The mechanisms and prevention of intravascular fluid loss after occlusion of the supraceliac aorta in dogs
75. Hypoxic reperfusion attenuates postischemic microvascular injury
76. Salvage of skeletal muscle with free radical scavengers
77. Gradual reintroduction of oxygen reduces reperfusion injury in cat stomach
78. Pulmonary hypertension and leukosequestration after lower torso ischemia
79. Adherent neutrophils mediate permeability after atelectasis
80. Prevention of hypotension following release of aortic occlusion
81. Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog
82. The role of heparin in prolonging acute renal ischemia time
83. Temporary experimental intracranial vascular occlusion: Effect of massive doses of heparin on brain survival
84. Heparinization reduces endothelial permeability and hydrogen ion accumulation in a canine skeletal muscle ischemia-reperfusion model
85. Actions and functions of heparin
86. Heparin: An old drug with a new paradigm
87. 1 esterase inhibitor activity by heparin
88. The observation of heparin on the endothelium
89. Vascular sequestration of heparin
90. Binding of heparin on the surface of cultured human endothelial cells
91. Temporary cerebral ischemia: Effects of pentastarch or albumin on reperfusion injury
92. Hetastarch decreases lung injury after descending thoracic aorta occlusion and reperfusion in rabbits
93. A biophysical approach to capillary permeability
94. Advantages of narrow range, medium molecular weight hydroxyethyl starch for volume maintenance in a porcine model of fecal peritonitis
95. Neutrophil elastase and oxygen radicals: Synergism in lung injury after hindlimb ischemia
96. Pulmonary edema after aneurysm surgery is modified by mannitol
97. Thromboxane mediates the ischemia induced neutrophil oxidative burst
98. Complement and anaphylatoxin responses in cross-clamping of the aorta
99. Influence of C3a anaphylatoxin compared to other vasoactive agents on the microcirculation on the rabbit omentum
100. Complement anaphylatoxins as plasma mediators, spasmogens and chemotaxins
101. Anaphylatoxin-induced shock and two patterns of anaphylactic shock: Hemodynamics and mediators
102. C5a-induced tracheal contraction: A histamine independent mechanism
103. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels
104. Lysosomal enzyme release from human leukocytes: Mediation by the alternative pathway of complement activation
105. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes
106. Cardiac dysfunction caused by purified human C3a anaphylatoxin
107. Origin of myocardial depressant factor in shock
108. Endotoxemia after major vascular operations
109. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury
110. The effect of infrarenal aortic reconstruction on glomerular filtration rate and effective renal plasma flow
111. Graft replacement of aneurysm in descending thoracic aorta: Results without bypass or shunting
112. Descending aortic aneurysmectomy without adjuncts to avoid ischemia
113. Spinal cord complications following surgery for coarctation of the aorta
114. Reappraisal of adjuncts to avoid ischemia in the treatment of aneurysms of the descending thoracic aorta
115. Surgical treatment of aneurysms of the descending thoracic aorta
116. Surgical experience in descending thoracic aneurysmectomy with and without adjuncts to avoid ischemia
117. Early and late results following repair of dissections of the descending thoracic aorta
118. Evolving concepts in prevention of spinal cord injury during operations on the descending thoracic and thoracoabdominal aorta
119. Protecting the brain and spinal cord
120. Paraplegia after thoracic aortic occlusion: Influence of cerebrospinal fluid drainage
121. Intrathecal papaverine for the prevention of paraplegia after operation on the thoracic or thoracoabdominal aorta
122. Effects of thoracic aorta occlusion and cerebrospinal fluid drainage on regional spinal cord blood flow in dogs: Correlation with neurologic outcome
123. Observed incidence of paraplegia after infrarenal aortic aneurysm repair
124. Incremental risk factors for spinal cord injury following operation for acute traumatic aortic transection
125. Phlebotomy reverses the hemodynamic consequences-of thoracic aortic cross-clamping: Relationships between central venous pressure and cerebrospinal fluid pressure
126. Longitudinal study of cerebral spinal fluid drainage in polyethylene glycol conjugated superoxide dismutase in paraplegia associated with thoracic aortic cross-clamping
127. Pharmacologic interventions for prevention of spinal cord injury caused by aortic crossclamping
128. Reducing postischemic paraplegia using conjugated superoxide dismutase
129. Paraplegia following aortic surgery
130. Regional blood flow during cross-clamping of the thoracic aorta and infusion of sodium nitroprusside
131. Cerebrospinal fluid drainage and steroids provide better spinal cord protection during aortic cross-clamping than does either treatment alone
132. Spinal cord injury in experimental thoracic aortic occlusion: Investigation of combined methods of protection
133. A new and simple method of preventing spinal cord damage following temporary occlusion of the thoracic aorta by draining the cerebrospinal fluid
134. The mechanism of paraplegia after temporary thoracic aortic occlusion and its relationship to spinal fluid pressure
135. The use of hypothermia in the prevention of paraplegia following temporary aortic occlusion: Experimental observations
136. Intraoperative management of the thoracic aorta aneurysm: Experimental evaluation of perfusion cooling of the spinal cord
137. Hypothermic regional perfusion for protection of the spinal cord during periods of ischemia
138. Selective deep hypothermia of the spinal cord prevents paraplegia after aortic cross-clamping in the dog model
139. Cerebral protection by barbiturate anesthesia: Use after middle cerebral artery occlusion in Java monkeys
140. Antioxidant effects of barbiturates in model membranes undergoing free radical damage
141. Prevention of ischemic spinal cord injury following aortic cross-clamping: Use of corticosteroids
142. Dexamethasone treatment during hemorrhage shock: Changes in extracellular fluid volume and cell membrane transport
143. +)-ATPase, lipid peroxidation and alpha motor neuron function
144. +)-ATPase activity
145. Visceral ischemia following aortic surgery